RVL Pharmaceuticals
(NASDAQ:RVLP)
$1.41
00
At close: Jul 5
$1.36
-0.0500[-3.55%]
PreMarket: 4:02PM EDT
Day High/Low- - -
52 Week High/Low1.01 - 2.04
Open / Close- / -
Float / Outstanding41.1M / 83.5M
Vol / Avg.- / 81.7K
Mkt Cap117.8M
P/E-
50d Avg. Price1.37
Div / Yield-
Payout Ratio-
EPS-0.08
Total Float41.1M

RVL Pharmaceuticals (NASDAQ:RVLP), Earnings Estimates, EPS, and Revenue

RVL Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

May 12

EPS

$-0.080

Quarterly Revenue

$21.4M

Annual Revenue (as of Mar 31)

$21.4M

Earnings History

Analyze the earnings history of RVL Pharmaceuticals using advanced sorting and filters.

Date
time
Quarter
Prior EPS
Est EPS
Actual EPS
EPS Surprise
Prior Rev
Est Rev
Actual Rev
Rev Surprise
Get Alert

RVL Pharmaceuticals Questions & Answers

Q
When is RVL Pharmaceuticals (NASDAQ:RVLP) reporting earnings?
A

RVL Pharmaceuticals (RVLP) is scheduled to report earnings on August 15, 2022. The last reported earnings were for reported on May 12, 2022 for Q1.

Q
What were the latest earnings per share (EPS) for RVL Pharmaceuticals (NASDAQ:RVLP)?
A

The Actual EPS was $1.18, which beat the estimate of $-0.07.

Q
What were RVL Pharmaceuticals’s (NASDAQ:RVLP) revenues?
A

The Actual Revenue was $66.3M, which missed the estimate of $69.3M.

Browse earnings estimates, EPS, and revenue on all stocks.